Publication:
Uvulopalatal flap for obstructive sleep apnea on an outpatient basis

0
0

Issued Date

2002

Resource Type

Article

File Type

application/pdf

ISSN

13412051

Other identifier(s)

2-s2.0-0036236782

Rights Holder(s)

Scopus

Bibliographic Citation

International Medical Journal. Vol 9, No.1 (2002), p.45-49

Suggested Citation

Neruntarat C. Uvulopalatal flap for obstructive sleep apnea on an outpatient basis. International Medical Journal. Vol 9, No.1 (2002), p.45-49. Retrieved from: https://hdl.handle.net/20.500.14740/6815

Title

Uvulopalatal flap for obstructive sleep apnea on an outpatient basis

Author(s)

Neruntarat C.

Abstract

Objective: Obstructive sleep apnea (OSA) is now seen as one end of a spectrum of sleep-related breathing disorders. It is associated with hypertension, cardiovascular diseases, daytime sleepiness and risk for general anesthesia. Since the introduction of uvulopalatopharyngoplasty (UPPP), many other procedures have been introduced to alleviate palatal abnormalities seen in patients with OSA. A reversible uvulopalatal flap (UPF) performed under general anesthesia also achieves the same results as UPPP, but with less postoperative discomfort. The purpose of this study was to assess the safety and efficacy of UPF for the treatment of OSA on an outpatient basis. Methods: UPF was performed in 36 OSA patients on an outpatient basis under local anesthesia. The mucosa on the lingual surface of the uvula and soft palate was removed with cold-knife dissection. The uvular tip was amputated. The uvula was reflected back toward the soft palate and sutured. Data on patients were compared from preoperative to postoperative assessment points. Statistical analysis was performed using Student t test. Results: Patients had a mean age of 30.2 years and a mean body mass index of 28.5 kg/m2. Most of the patients were male. All patients tolerated the procedure well and it was performed in an average of 20 minutes. The mean follow-up was 6 months (range 4-8 months). Responders were defined as OSA patients who had a reduction in RDI of 50% or more and RDI of 10 or less after surgery. By these criteria, 52% of patients were considered to have responded to UPF. Mean RDI improved from 45.2±10.2 to 10.1±4.2 (p<0.001). The Epworth sleepiness scale improved from 12.5 ± 5.4 to 8.2 ± 4.8 (p<0.001). Postoperative complications included transient nasal regurgitation in 11.1% and foreign body sensation in 8.3%. Bleeding, dysphasia, infection, and nasopharyngeal stenosis were not observed. Most patients had mild-to-moderate pain (visual analog scale ≤ 7) for 5 to 7 days after procedure. Conclusion: UPF results in both significant reductions in respiratory disturbance index and clinical improvements in snoring and sleepiness. It appears to be a well-tolerated outpatient surgical procedure for the treatment of OSA.

Subject(s)

Adult
 Ambulatory surgery
 Article
 Bleeding
 Body mass
 Breathing disorder
 Dysphagia
 Female
 Foreign body
 General anesthesia
 Human
 Infection
 Local anesthesia
 Major clinical study
 Male
 Muscle flap
 Nasopharynx stenosis
 Nose regurgitation
 Pain assessment
 Patient selection
 Polysomnography
 Postoperative complication
 Respiratory distress
 Scoring system
 Sleep apnea syndrome
 Snoring
 Somnolence
 Statistical analysis
 Uvulopalatal flap
 Uvulopalatopharyngoplasty

View online Resources

Research Projects

Organizational Units

Journal Issue

URI

https://hdl.handle.net/20.500.14740/6815

Collections

Scopus: Year 1983-2021

Endorsement

Review

Supplemented By

Referenced By